Lomotil Tablet
NDC Package 0025-0061-31
Package Information
Lomotil (diphenoxylate hydrochloride and atropine sulfate) tablets is lomotil is indicated as adjunctive therapy in the management of diarrhea in patients 13 years of age and older. This formulation utilizes a tablet delivery system. Marketed by Pfizer Laboratories Div Pfizer Inc, this product is identified by NDC 0025-0061 and is authorized under FDA application NDA012462.
Identification & Billing
- RxCUI: 1190572 - diphenoxylate HCl 2.5 MG / atropine sulfate 0.025 MG Oral Tablet
- RxCUI: 1190572 - atropine sulfate 0.025 MG / diphenoxylate hydrochloride 2.5 MG Oral Tablet
- RxCUI: 1190641 - Lomotil 2.5 MG / 0.025 MG Oral Tablet
- RxCUI: 1190641 - atropine sulfate 0.025 MG / diphenoxylate hydrochloride 2.5 MG Oral Tablet [Lomotil]
- RxCUI: 1190641 - Lomotil (atropine sulfate 0.025 MG / diphenoxylate hydrochloride 2.5 MG) Oral Tablet
Clinical Specifications
- Anticholinergic - [EPC] (Established Pharmacologic Class)
- Antidiarrheal - [EPC] (Established Pharmacologic Class)
- Cholinergic Antagonists - [MoA] (Mechanism of Action)
- Cholinergic Muscarinic Antagonist - [EPC] (Established Pharmacologic Class)
- Cholinergic Muscarinic Antagonists - [MoA] (Mechanism of Action)
Regulatory & Marketing
Hierarchy Structure
- 0025 - Pfizer Laboratories Div Pfizer Inc
- 0025-0061 - Lomotil
- 0025-0061-31 - 100 TABLET in 1 BOTTLE
- 0025-0061 - Lomotil
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0025-0061-31 identifies a specific commercial package of 100 tablet in 1 bottle of Lomotil, a human prescription drug labeled by Pfizer Laboratories Div Pfizer Inc. This tablet is formulated for oral use and contains diphenoxylate hydrochloride; atropine sulfate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Pfizer Laboratories Div Pfizer Inc on September 15, 1960. The current certification is valid through December 31, 2027.
How is this Pfizer Laboratories Div Pfizer Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00025006131. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.